Severe ROP in twins after blockage of the renin-angiotensin system during gestation

被引:7
作者
Hard, Anna-Lena [1 ]
Wennerholm, Ulla-Britt [2 ]
Niklasson, Aimon [3 ]
Hellstrom, Ann [1 ,3 ]
机构
[1] Queen Silvia Childrens Hosp, Dept Pediat Ophthalmol, Inst Neurosci & Physiol, S-41685 Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Obstet & Gynecol, Gothenburg, Sweden
[3] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Pediat,Goteborg Pediat Growth Res Ctr, Gothenburg, Sweden
关键词
gastroschisis; intestinal growth and adaptation; short bowel syndrome;
D O I
10.1111/j.1651-2227.2008.00851.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Blockage of the renin-angiotensin system (RAS) during pregnancy is known to cause serious dysfunction of many organs of the foetus and newborn. Angiotensin II is an angiogenic factor and angiotensin-converting enzyme (ACE) inhibitors prevent retinal neovascularisation and their use in preventing proliferative retinopathy of prematurity has been suggested. We report on twin girls born after 32 gestational weeks, who were exposed to blockage of the RAS during gestation, had severely reduced retinal vasculature and developed severe retinopathy of prematurity (ROP) despite receiving very little extra oxygen. Conclusion: It is likely that ACE inhibitors and angiotensin receptor blockers not only reduce pathological neovascularisation but also normal vascularisation of the eyes and other organs.
引用
收藏
页码:1142 / 1144
页数:4
相关论文
共 12 条
[1]   TERATOGEN UPDATE - ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS [J].
BARR, M .
TERATOLOGY, 1994, 50 (06) :399-409
[2]  
BERKA JL, 1995, INVEST OPHTH VIS SCI, V36, P1450
[3]   Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes [J].
Chaturvedi, N ;
Sjolie, AK ;
Stephenson, JM ;
Abrahamian, H ;
Keipes, M ;
Castellarin, A ;
Rogulja-Pepeonik, Z ;
Fuller, JH .
LANCET, 1998, 351 (9095) :28-31
[4]   The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study [J].
Diav-Citrin, O ;
Arnon, J ;
Shechtman, S ;
Schaefer, C ;
Tonningen, MR ;
Clementi, M ;
Santis, M ;
Robert-Gnansia, E ;
Valti, E ;
Malm, H ;
Ornoy, A .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (03) :269-275
[5]   Retinopathy of prematurity in assisted versus natural conception and singleton versus multiple births [J].
Friling, Ronit ;
Axer-Siegel, Ruth ;
Hersocovici, Zvi ;
Weinberger, Dov ;
Sirota, Lea ;
Snir, Moshe .
OPHTHALMOLOGY, 2007, 114 (02) :321-324
[6]   Incidence of ROP in two consecutive Swedish population based studies [J].
Larsson, E ;
Carle-Petrelius, B ;
Cernerud, G ;
Ots, L ;
Wallin, A ;
Holmström, G .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2002, 86 (10) :1122-1126
[7]   Retinal neovascularization is prevented by blockade of the renin-angiotensin system [J].
Moravski, CJ ;
Kelly, DJ ;
Cooper, ME ;
Gilbert, RE ;
Bertram, JF ;
Shahinfar, S ;
Skinner, SL ;
Wilkinson-Berka, JL .
HYPERTENSION, 2000, 36 (06) :1099-1104
[8]   Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells [J].
Otani, A ;
Takagi, H ;
Suzuma, K ;
Honda, Y .
CIRCULATION RESEARCH, 1998, 82 (05) :619-628
[9]   Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists [J].
Quan, A .
EARLY HUMAN DEVELOPMENT, 2006, 82 (01) :23-28
[10]   Drugs during pregnancy - An issue of risk classification and information to prescribers [J].
Sannerstedt, R ;
Lundborg, P ;
Danielsson, BR ;
Kihlstrom, I ;
Alvan, G ;
Prame, B ;
Ridley, E .
DRUG SAFETY, 1996, 14 (02) :69-77